T3 Defense Inc. DFNS
7.79
(0.08)
(1.02%)
as of 25 Sep
- Market cap
- $22.3M
- P/E
- 0.0×
Follow DFNS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | 0.00 | 0.00 |
P/S ratio |
— | — | 4.41 | 1.23 | |
P/FCF ratio |
— | — | 0.00 | 0.00 | |
P/Operating CF |
— | — | (4.10) | (2.11) | |
P/B ratio |
— | — | 0.47 | 0.00 | |
Price to Tangible BV |
— | — | 0.00 | 0.00 | |
EV/Sales |
— | — | 4.28 | 1.28 | |
EV/EBITDA |
— | — | 0.00 | 0.00 | |
EV/Operating CF |
— | — | (2.01) | (0.80) | |
EV/FCF |
— | — | (1.96) | (0.78) | |
Quick Ratio |
0.17 | 0.11 | 0.13 | 0.07 | |
Current Ratio |
0.30 | 0.31 | 0.25 | 0.14 | |
Net Debt/EBITDA |
1.60 | 0.13 | 0.16 | (0.13) | |
Debt/Assets |
0.00% | 0.43% | 2.30% | 2.47% | |
Debt/Equity |
0.00 | (0.06) | 0.17 | (0.40) | |
Asset Turnover |
0.00 | 0.00 | 0.03 | 0.05 | |
Operating CF/Net income |
0.15 | 0.09 | 0.18 | 0.06 | |
Capex/Depreciation |
(8.90) | 0.04 | (0.82) | (0.72) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | — | 7.50% | 8.71% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 106.98% | 101.18% | |
Intangible Assets out of Total Assets |
0.00 | 0.07 | 0.36 | 0.35 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 52.20% | 0.00% | |
Graham Net Nets |
— | — | (12.39) | (30.64) | |
Graham Number |
— | — | 0.00 | 1,285.25 | |
Earnings Yield |
— | — | (1,886.93%) | (8,384.27%) | |
Free Cash Flow Yield |
— | — | (49.67%) | (133.71%) | |
Revenue per Share |
0.00 | 0.00 | 16.21 | 8.33 | |
Operating CF per Share |
(38.54) | (14.93) | (21.87) | (10.13) | |
Capex per Share |
(0.29) | (0.18) | (0.68) | (0.37) | |
Free Cash Flow per Share |
(38.83) | (15.11) | (22.55) | (10.51) | |
Cash per Share |
117.10 | 62.74 | 34.69 | 15.37 | |
Shareholders Equity per Share |
(467.97) | (232.87) | 188.74 | (40.96) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(467.97) | (232.87) | 188.74 | (40.96) | |
Free Cash Flow |
(2.52) | (1.01) | (5.08) | (5.04) | |
Working Capital |
(30.51) | (29.99) | (68.81) | (131.95) | |
Capital Expenditures |
(0.02) | (0.01) | (0.15) | (0.18) | |
Net Current Asset Value |
(30.59) | (204.41) | (250.15) | (314.42) | |
EV/EBIT |
— | — | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.04 | 0.05 | |
Net Profit Margin |
0.00% | 0.00% | (743.14%) | (2,037.79%) | |
Price to Operating Income |
— | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | — | 2.05 | 2.29 | |
Average Payables |
0.68 | 0.10 | 5.57 | 2.43 | |
Average Assets |
6.64 | 105.75 | 162.04 | 161.57 | |
Average Common Equity |
(18.76) | (89.46) | (7.35) | (36.52) |
Columns are period end dates